ConductScience.org, home

Paper41540320

A novel murine model of LITT for glioblastoma reveals tumor reduction, BBB permeabilization, and drug delivery via ThermoDox®.

Athukuri P and 10 others. Drug Deliv Transl Res, 2026. Cited by 1 paper, by iCite.

Cite this record

ConductScience Library. A novel murine model of LITT for glioblastoma reveals tumor reduction, BBB permeabilization, and drug delivery via ThermoDox®. Papers, record 41540320. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41540320

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
A novel murine model of LITT for glioblastoma reveals tumor reduction, BBB permeabilization, and drug delivery via ThermoDox®.
PubMed
Journal
Drug Deliv Transl Res
PubMed
Year
2026
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
1
iCite
Revised in PubMed
2026-11-05
PubMed

Authors11

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Athukuri PPrazwal
2Moreno KKarina
3McDonald MFMalcolm F
4Puentes AAshley
5Dei-Ampeh AAlfred
6Marisetty AAnantha
7Yang YYuhui
8Lee SSungho
9Latha KKhatri
10Needham DDavid
11Rao GGaneshhttps://orcid.org/0000-0003-3609-3491

Source PubMed

Download CSV of authors

Topics14

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Blood-Brain BarrierMajor topic
Brain NeoplasmsMajor topic
DoxorubicinMajor topic
GlioblastomaMajor topic
Laser TherapyMajor topic
Antibiotics, AntineoplasticMajor topic
Hyperthermia, InducedMajor topic
Animals
Cell Line, Tumor
Disease Models, Animal
Drug Delivery Systems
Mice
Mice, Inbred C57BL
Humans

Source PubMed

Download CSV of topics

Grants2

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
R21 NS123589NINDS NIH HHSUnited StatesR21NS123589PubMed
R21NS123589NINDS NIH HHSUnited StatesR21NS123589PubMed

Source NIH RePORTER

Download CSV of grants

References41

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
116091763Resistance to tumour challenge after tumour laser thermotherapy is associated with a cellular immune response.Br J Cancer2005https://conductscience.org/library/papers/16091763PubMed
222178041Phase I study of heat-deployed liposomal doxorubicin during radiofrequency ablation for hepatic malignancies.J Vasc Interv Radiol2012https://conductscience.org/library/papers/22178041PubMed
37693418Epirubicin. Clinical pharmacology and dose-effect relationship.Drugs1993https://conductscience.org/library/papers/7693418PubMed
435104794Syngeneic murine glioblastoma models: reactionary immune changes and immunotherapy intervention outcomes.Neurosurg Focus2022https://conductscience.org/library/papers/35104794PubMed
536632307Survival and quality of life analysis in glioblastoma multiforme with adjuvant chemoradiotherapy: a retrospective study.Rep Pract Oncol Radiother2022https://conductscience.org/library/papers/36632307PubMed
634205567Measurement of Ex Vivo Liver, Brain and Pancreas Thermal Properties as Function of Temperature.Sensors (Basel)2021https://conductscience.org/library/papers/34205567PubMed
723560574Results of the NeuroBlate System first-in-humans Phase I clinical trial for recurrent glioblastoma: clinical article.J Neurosurg2013https://conductscience.org/library/papers/23560574PubMed
835489652Laser ablation: Heating up the anti-tumor response in the intracranial compartment.Adv Drug Deliv Rev2022https://conductscience.org/library/papers/35489652PubMed
929849513Evans Blue Dye: A Revisit of Its Applications in Biomedicine.Contrast Media Mol Imaging2018https://conductscience.org/library/papers/29849513PubMed
1010969790Hyperthermia enables tumor-specific nanoparticle delivery: effect of particle size.Cancer Res2000https://conductscience.org/library/papers/10969790PubMed
1124561446Thermal ablation of tumours: biological mechanisms and advances in therapy.Nat Rev Cancer2014https://conductscience.org/library/papers/24561446PubMed
1210728674A new temperature-sensitive liposome for use with mild hyperthermia: characterization and testing in a human tumor xenograft model.Cancer Res2000https://conductscience.org/library/papers/10728674PubMed
1322952218Overcoming limitations in nanoparticle drug delivery: triggered, intravascular release to improve drug penetration into tumors.Cancer Res2012https://conductscience.org/library/papers/22952218PubMed
1434554269Adaptation of laser interstitial thermal therapy for tumor ablation under MRI monitoring in a rat orthotopic model of glioblastoma.Acta Neurochir (Wien)2021https://conductscience.org/library/papers/34554269PubMed
1530202239Sulbactam-enhanced cytotoxicity of doxorubicin in breast cancer cells.Cancer Cell Int2018https://conductscience.org/library/papers/30202239PubMed
1632672122The use of laser interstitial thermal therapy in the treatment of brain metastases: a literature review.Int J Hyperthermia2020https://conductscience.org/library/papers/32672122PubMed
1732793888Laser interstitial thermal therapy.Neurooncol Adv2020https://conductscience.org/library/papers/32793888PubMed
1832666049Therapeutic enhancement of blood-brain and blood-tumor barriers permeability by laser interstitial thermal therapy.Neurooncol Adv2020https://conductscience.org/library/papers/32666049PubMed
1927861323Stereotactic Laser Interstitial Thermal Therapy for Recurrent High-Grade Gliomas.Neurosurgery2016https://conductscience.org/library/papers/27861323PubMed
209738985Antitumor immunity induction by intracellular hyperthermia using magnetite cationic liposomes.Jpn J Cancer Res1998https://conductscience.org/library/papers/9738985PubMed

See all 41 referencesDownload CSV of references

Cited by3

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1 citation.

PMIDTitleJournalYearIn PapersSource
42978966Intranasal nano-immunotherapy for glioma: bypassing the blood-brain barrier, reprogramming the immune microenvironment, and bridging preclinical validation.Front Immunol2026https://conductscience.org/library/papers/42978966PubMed
42883298Recent Advances in Small-Molecule-Based Nanovectors for the Treatment of Colorectal Cancer.Molecules2026https://conductscience.org/library/papers/42883298PubMed
42265512Laser interstitial thermal therapy (LITT) for brain metastases: a systematic review and pooled analysis of Efficacy/Safety and the role of combination treatments.J Neurooncol2026https://conductscience.org/library/papers/42265512PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41540320

GET https://conductscience.org/api/papers/v1/41540320/references?page=2